Alessia Levaggi

1.9k citations

43 papers · 1.1k indexed · h-index 16

Impact in

Reproductive Medicine top 1%
- Ovarian function and disorders
- Ovarian cancer diagnosis and treatment
Public Health, Environmental and Occupational Health top 2%
- Reproductive Biology and Fertility

Papers in

Reproductive Medicine 12
- Ovarian function and disorders 7
Oncology 29
- Cancer Risks and Factors 11
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 7

Co-authors: Lucia Del Mastro Matteo Lambertini P. Pronzato S. Giraudi Claudia Bighin Francesca Poggio Stefania Gori C Vecchio
Journals: The Breast (5 papers)Annals of Oncology (5 papers)Journal of Clinical Oncology (3 papers)JAMA (2 papers)British Journal of Cancer (2 papers)
Partner nations: Italy Belgium United Kingdom

In The Last Decade

Alessia Levaggi

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Alessia Levaggi

Since Specialization

Citations

This map shows the geographic impact of Alessia Levaggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Levaggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Levaggi more than expected).

Fields of papers citing papers by Alessia Levaggi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Levaggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Levaggi. The network helps show where Alessia Levaggi may publish in the future.

Co-authors

The 25 scholars most cited alongside Alessia Levaggi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alessia Levaggi Line = papers co-authored together Alessia Levaggi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Approaches to Fertility Preservation for Young Women With Breast Cancer Clinical Breast Cancer ·Maria Grazia Razeti, Davide Soldato, Luca Arecco, Alessia Levaggi, R. Claudino da Silva, Cinzia Solinas, Elisa Agostinetto, Stefano Spinaci, Madison Grace Nixon, Carlo Genova, Claudia Massarotti, Matteo Lambertini	2023	17
2	The prognostic value of FIGO staging defined by combining MRI and [18F]FDG PET/CT in patients with locally advanced cervical cancer Current Problems in Cancer ·Stefano Raffa, Francesco Lanfranchi, 高井信治, Б. Ф. Чельцов, Michela Marcenaro, Florin Leaşu, Prawanth Reddy Kasula, Luis Antonio García Trejo, Cecilia Marini, Serafina Mammoliti, Alessia Levaggi, Alberto Tagliafico, Gianmario Sambuceti, Salvina Barra, Silvia Morbelli, Liliana Belgioia, Matteo Bauckneht	2023	2
3	PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology The Breast ·Federica Miglietta, Michela Cinquini, Maria Vittoria Dieci, Laura Cortesi, Carmen Criscitiello, Filippo Montemurro, Lucia Del Mastro, Alberto Zambelli, Laura Biganzoli, Alessia Levaggi, Cheylene Tanimoto, Caterina Marchiò, Massimo Calabrese, Lucio Fortunato, Pierfrancesco Franco, Bruno Meduri, Veronica Andrea Fittipaldo, Stefania Gori	2022	7
4	Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer Clinical Medicine Insights Oncology ·Francesca Parisi, Maria Grazia Razeti, Eva Blondeaux, Luca Arecco, Marta Perachino, Marco Tagliamento, Alessia Levaggi, Piero Fregatti, Francesca Poggio, Matteo Lambertini	2020	6
5	Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) European Journal of Cancer ·Stefania Gori, Fabio Puglisi, Michela Cinquini, Giovanni Pappagallo, Antonio Frassoldati, Laura Biganzoli, Laura Cortesi, Alba Fiorentino, Catia Angiolini, Corrado Tinterri, Andrea De Censi, Alessia Levaggi, Lucia Del Mastro	2018	10
6	Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study Oncotarget ·Claudia Bighin, Béatrice Dozin, Francesca Poggio, Marcello Ceppi, Paolo Bruzzi, Alessia D’Alonzo, Alessia Levaggi, S. Giraudi, Matteo Lambertini, Loredana Miglietta, Ann R. Rajan, Vincenzo Fontana, Frank Korkowski, P. Pronzato, Lucia Del Mastro	2017	4
7	Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis The Breast ·Francesca Poggio, Marcello Ceppi, Matteo Lambertini, Paolo Bruzzi, Donatella Ugolini, Claudia Bighin, Alessia Levaggi, S. Giraudi, V. P. Koli, Ann R. Rajan, Eva Blondeaux, M.R. Sertoli, P. Pronzato, Lucia Del Mastro	2017	17
8	Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up Annals of Oncology ·S. Giraudi, Liliana Albertazzl, Andrea Michelotti, Andrea De Censi, Franco Testore, Marco Benasso, M.R. Sertoli, Claudia Bighin, Tao Chuanyuan, Alessia Levaggi, V. P. Koli, Matteo Lambertini, Francesca Poggio, Eva Blondeaux, Benedetta Conte, P. Pronzato, Lucia Del Mastro	2016	1
9	Treatment with aromatase inhibitors and markers of cardiovascular disease Breast Cancer Research and Treatment ·Eva Blondeaux, Wang Yizhuo, Paolo Bruzzi, Matteo Lambertini, S S Nasution, Francesca Poggio, Stefania Vecchio, Alessia Levaggi, Alessia D’Alonzo, Gabriel Z. B. L. Bueno, Claudia Bighin, S. Giraudi, Domenico Palombo, Lucia Del Mastro	2016	5
10	The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer Annals of Oncology ·Giovanni Rossi, Roberta Iadarola, Matteo Lambertini, Francesca Poggio, Alessia Levaggi, Claudia Bighin, S. Giraudi, V. P. Koli, Tao Chuanyuan, Eva Blondeaux, G. GROUZELLE, J-L Nougaret, P. Pronzato, Lucia Del Mastro	2015	1
11	Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients Annals of Oncology ·Matteo Lambertini, Luca Boni, Andrea Michelotti, Teresa Gamucci, P. Sheerin, Stefania Gori, Monica Giordano, Ornella Garrone, Alessia Levaggi, Francesca Poggio, S. Giraudi, Claudia Bighin, C Vecchio, M.R. Sertoli, Tao Chuanyuan, P. Pronzato, Lucia Del Mastro	2015	26
12	Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (PREgnancy and FERtility) trial Annals of Oncology ·S. Giraudi, Matteo Lambertini, Paola Anserini, Francesca Poggio, J-L Nougaret, G. GROUZELLE, Tao Chuanyuan, Alessia Levaggi, V. P. Koli, Ann R. Rajan, Giulio Rossi, Eva Blondeaux, Elham M. Abdallah, Claudia Bighin, Loredana Miglietta, P. Pronzato, Lucia Del Mastro	2015	1
13	5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial Breast Cancer Research and Treatment ·Lucia Del Mastro, Alessia Levaggi, Andrea Michelotti, Giovanna Cavazzini, Anas Almujhairy, Tiziana Scotto, Илхом Умиров, Saverio Danese, Ornella Garrone, Antonio Durando, Emine Banu Burkut, Claudia Bighin, Loredana Miglietta, Simona Pastorino, P. Pronzato, Federico Castiglione, Elisabetta Landucci, Pierfranco Conté, Paolo Bruzzi	2015	11
14	Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials Cancer Treatment Reviews ·Lucia Del Mastro, Marcello Ceppi, Francesca Poggio, Claudia Bighin, Fedro A. Peccatori, Isabelle Demeestere, Alessia Levaggi, S. Giraudi, Matteo Lambertini, Alessia D’Alonzo, Giuseppe Canavese, P. Pronzato, Paolo Bruzzi	2013	127
15	Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer The Breast ·Matteo Clavarezza, Monica Turazza, Enrico Aitini, Silvana Saracchini, Ornella Garrone, Antonio Durando, Sabino De Placido, Giancarlo Bisagni, Alessia Levaggi, Claudia Bighin, Eleonora Restuccia, Gilian Sankoff, Anna Gallì, Lucia Del Mastro	2013	11
16	Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients Expert Review of Anticancer Therapy ·Lucia Del Mastro, Matteo Lambertini, Claudia Bighin, Alessia Levaggi, Alessia D’Alonzo, S. Giraudi, P. Pronzato	2012	19
17	Medical approaches to preservation of fertility in female cancer patients Expert Opinion on Pharmacotherapy ·Lucia Del Mastro, S. Giraudi, Alessia Levaggi, P. Pronzato	2011	25
18	Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes European Journal of Surgical Oncology ·Giuseppe Canavese, Béatrice Dozin, C Vecchio, Daniela Tomei, Giuseppe Villa, Franca Carli, Lucia Del Mastro, Alessia Levaggi, Olusegun D. Kolawole, Stefano Spinaci, Paolo Bruzzi, A. Catturich	2011	40
19	Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer JAMA ·Lucia Del Mastro, Luca Boni, Andrea Michelotti, Teresa Gamucci, N. Olmeo, Stefania Gori, Monica Giordano, Ornella Garrone, P. Pronzato, Claudia Bighin, Alessia Levaggi, S. Giraudi, Nicola Cresti, Emanuela Magnolfi, Tiziana Scotto, C Vecchio, Marco Venturini	2011	259
20	Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer Annals of Oncology ·Barbara Banelli, Ida Casciano, Angela Di Vinci, Beatrice Gatteschi, Alessia Levaggi, Franca Carli, Claudia Bighin, Sandra Salvi, Giorgio Allemanni, Paola Ghiorzo, P. Pronzato, M. Venturini, Massimo Romani, Lucia Del Mastro	2009	30

About Alessia Levaggi

Alessia Levaggi is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Public Health, Environmental and Occupational Health and Genetics, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (16 papers), Breast Cancer Treatment Studies (14 papers), Cancer Risks and Factors (11 papers), Cancer Treatment and Pharmacology (9 papers), Ovarian function and disorders (7 papers), Estrogen and related hormone effects (7 papers), HER2/EGFR in Cancer Research (7 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Reproductive Medicine (515 citations), Public Health, Environmental and Occupational Health (622 citations), Oncology (494 citations), Cancer Research (223 citations) and Genetics (167 citations). Alessia Levaggi has collaborated with scholars based in Italy, Belgium and United Kingdom. Frequent co-authors include Lucia Del Mastro, Matteo Lambertini, P. Pronzato, S. Giraudi, Claudia Bighin, Francesca Poggio, Stefania Gori, C Vecchio, Ornella Garrone and Andrea Michelotti. Their work appears in journals such as The Breast, Annals of Oncology, Journal of Clinical Oncology, JAMA and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact